The National Center for Minimal Access Surgery (CNCMA by its Spanish acronym) first in Cuba of this branch of medicine, made more than 4,500 such surgical procedures in 2016, with very good results, announced the director of that institution.
With nearly 200 patients, a clinical trial of the drug Cimavax EGF against lung cancer in primary health care (PHC) is being developed in Cuba to evaluate other parameters in order to increase the effectiveness of the first vaccine of its type registered in the world.
World Health Day will be dedicated this year to depression currently affecting 300 million people in the world.
The University of Medical Sciences of Havana (UCMH) and the Faculty of Health Technology convene the Third International Convention on Technology and Health, which will be held from 27 to 31 this month in Havana.
Dr. Peter Courtland Agre, US biologist and university professor who was awarded the 2003 Nobel Prize in Chemistry, is the new Corresponding Member of the Cuban Academy of Sciences (ACC by its Spanish acronym).
Specialists say that kidney diseases can be prevented with education, knowledge, and a healthy lifestyle including an adequate nutrition and exercise.
Cuban scientific centers headed by the Ministry of Higher Education (MES) recognized on Wednesday the work of the Indio Hatuey Station located in Matanzas province for its contribution to the development of science, technology and innovation for the last 55 years.
A clinical trial with Heberferon will begin this year in Cuba in about 300 patients with renal carcinoma, announced Dr. Iraldo Bello, expert who developed the product at the Center for Genetic Engineering and Biotechnology (CIGB by its Spanish acronym).
Twenty Cuban patients with Parkinson's disease underwent deep brain stimulation surgery, since this type of medical intervention was resumed in November 2016 at Lucía Íñiguez Hospital, in the Cuban city of Holguín.
Heberferon, the new Cuban drug for the treatment of skin cancer obtained from biotechnological formulations, has been applied to some 800 patients in the country, the product researcher announced.
A therapeutic vaccine aimed at reducing the viral load of patients with Human Immunodeficiency Virus (HIV), which has an impact on the quality of life of patients, is currently in phase one of the clinical trial, in which its safety is studied.
Cuba's advances in the use of biotechnology for agricultural development, with results superior to many countries in the world, were highlighted during the second day of the first BioProcess Congress, which takes place in this city.
A total of 471 888 children will be immunized throughout Cuba against poliomyelitis in the 56th National Anti-Polio Vaccination Campaign, which first stage will be held from February 20 to 26.
Representatives from Cuba and France will sign a cooperation agreement today to create a joint scientific cooperation program.
The William Soler Pedriatric Hospital in Havana has reduced infant mortality in congenital heart conditions from 3.5 per one thousand live births in 1980 to less of 0.5 since 2015 according to the institution's statistics.